HJIM
AZN icon

Henry James International Management’s AstraZeneca AZN Stock Holding History

Henry James International Management’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.95M Sell
36,652
-1,840
-5% -$346K 2.08% 11
2026
Q1 		$7.59M Sell
38,492
-2
-0% -$386 2.74% 10
2025
Q4 		$7.08M Buy
38,494
+9,512
+33% +$1.67M 2.23% 13
2025
Q3 		$4.45M Hold
28,982
– – 1.36% 25
2025
Q2 		$4.05M Hold
28,982
– – 1.33% 27
2025
Q1 		$4.26M Hold
28,982
– – 1.46% 23
2024
Q4 		$3.8M Sell
28,982
-4,054
-12% -$568K 1.37% 26
2024
Q3 		$5.15M Sell
33,036
-761
-2% -$123K 1.79% 18
2024
Q2 		$5.27M Buy
33,797
+8,602
+34% +$1.29M 1.87% 17
2024
Q1 		$3.41M Buy
25,195
+9,779
+63% +$1.29M 1.05% 32
2023
Q4 		$2.08M Buy
15,416
+4,753
+45% +$618K 0.78% 42
2023
Q3 		$1.44M Buy
10,663
+6,175
+138% +$843K 0.63% 47
2023
Q2 		$642K Hold
4,488
– – 0.28% 67
2023
Q1 		$623K Hold
4,488
– – 0.26% 74
2022
Q4 		$609K Buy
4,488
+703
+19% +$88.2K 0.29% 72
2022
Q3 		$415K Hold
3,785
– – 0.23% 82
2022
Q2 		$500K Hold
3,785
– – 0.25% 79
2022
Q1 		$502K Hold
3,785
– – 0.2% 83
2021
Q4 		$441K Sell
3,785
-9
-0.2% -$1.06K 0.14% 113
2021
Q3 		$456K Hold
3,794
– – 0.14% 110
2021
Q2 		$454K Sell
3,794
-7
-0.2% -$768 0.13% 119
2021
Q1 		$378K Hold
3,801
– – 0.11% 136
2020
Q4 		$380K Sell
3,801
-950
-20% -$101K 0.13% 102
2020
Q3 		$521K Sell
4,751
-1,552
-25% -$173K 0.21% 80
2020
Q2 		$667K Sell
6,303
-110
-2% -$11.4K 0.28% 74
2020
Q1 		$573K Hold
6,413
– – 0.29% 76
2019
Q4 		$639K Hold
6,413
– – 0.25% 93
2019
Q3 		$572K Buy
6,413
+442
+7% +$38.3K 0.24% 93
2019
Q2 		$493K Sell
5,971
-127
-2% -$9.96K 0.21% 101
2019
Q1 		$493K Hold
6,098
– – 0.22% 97
2018
Q4 		$463K Buy
6,098
+350
+6% +$27.3K 0.3% 93
2018
Q3 		$455K Buy
+5,748
New +$435K 0.17% 182

Other funds holding AZN

RG
Rathbones Group Liverpool, United Kingdom $27.1B AUM 20.2% 1-Year Est. Return
CDDEC
Caisse Des Depots Et Consignations Paris, France $5.91B AUM 35.65% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
BTCPP
Border to Coast Pensions Partnership Leeds, United Kingdom $6.78B AUM 31.6% 1-Year Est. Return
AAMU
AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
ISS
Intesa Sanpaolo SpA. Turin, Italy $2.92B AUM
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
AIM
Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return

Henry James International Management's AZN Position: Q2 2026 in Review

Henry James International Management reduced its AstraZeneca (AZN) stake by 4.8% in Q2 2026, selling an estimated $346K and leaving 36,652 shares worth $6.95M. The position accounts for 2.08% of the portfolio, ranked #11.

Henry James International Management first reported a position in AZN in Q3 2018 and has held it in 32 quarters since. The position peaked at $7.59M in Q1 2026. 655 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

  • Henry James International Management held 36,652 shares of AstraZeneca worth $6.95M as of Q2 2026.
  • Henry James International Management sold 1,840 AstraZeneca shares in Q2 2026, an estimated $346K.
  • AstraZeneca made up 2.08% of Henry James International Management's portfolio in Q2 2026, its #11 holding.
  • Henry James International Management first reported a position in AstraZeneca in Q3 2018 and has held it in 32 quarters since.
  • Henry James International Management's AstraZeneca position peaked at $7.59M in Q1 2026.
  • 655 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Henry James International Management's 13F filing for Q2 2026, filed 9 Jul 2026.